Answers are grounded in this paper and cite their sources.
Traditional bulk transcriptome sequencing can only obtain the average expression signal of a cell population, cannot resolve cellular heterogeneity within tissues, and has difficulty revealing the mechanisms of dynamic changes in cell states and interactions with the microenvironment. Single-cell RNA sequencing (scRNA-seq) technology can resolve whole-transcriptome expression profiles at single-cell resolution, breaking through the technical bottleneck of population averaging, and has become a core disruptive biotechnology in the life sciences. This paper systematically sorts out the technical principles, mainstream experimental platforms, and microfluidic supporting technologies of scRNA-seq, and summarizes the core bioinformatics analysis methods and tool platforms such as single-cell data preprocessing, cellular heterogeneity resolution, and differentiation trajectory reconstruction; it focuses on the application progress of this technology in the construction of the human cell atlas, the resolution of the tumor microenvironment, the tracking of development and differentiation, cell communication analysis, and disease biomarker screening; it summarizes frontier technology directions such as single-cell multi-omics integration, spatial transcriptomics fusion, and CRISPR functional screening, and analyzes the current bottleneck problems of cost, throughput, and data analysis. Finally, combined with the trend of technological iteration, it looks forward to the future development directions of high throughput, low cost, multi-dimensional integration, and clinical translation, aiming to provide a systematic reference for the basic research and biomedical applications of single-cell sequencing technology.
No takes yet. Share an insight, caveat, or question.
Yunze Tao (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: